Clinical Impact of Clonal and Subclonal TP53 M... - CLL Support
Clinical Impact of Clonal and Subclonal TP53 Mutations in Chronic Lymphocytic Leukemia
You need to be a member of this community to see this post.
7 Replies
You need to be a member of this community to see hidden responses.
Not what you're looking for?
You may also like...
Chronic lymphocytic leukemia treatment algorithm 2022
This 29 November 2022 review article published in the Blood Cancer Journal presents an...
Clonal Evolution, mutations and resistance to CLL treatment
When someone is diagnosed with CLL they have at least one clone of B lymphocytes that are growing...
VenR in Relapsed CLL: 4-Year Results and Evaluation of Impact of Genomic Complexity and Gene Mutations from MURANO 3 study
This is an important evaluation and insight into how your CLL profile affects your response to VR...
"Accelerated" chronic lymphocytic leukemia/small lymphocytic lymphoma: unraveling CLL/SLL biological gray zone in the era of novel therapies
Encouraging news in this abstract from CLL/SLL researchers at the Northwestern Memorial Hospital,...
Clinical trial results on 17p & tp53 variants in treatment naïve & relapsed patients by Dr. Furman - Oct 2022 to medical professionals
This link: https://hmpeducation.com/content/access-webcast-133 will connect to a talk by Dr....